10
6
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13888 |
SLF
|
Others | Others |
SLF is a synthetic ligand for FK506-binding protein (FKBP)( with an affinity of 3.1 μM for FKBP51 and an IC50 of 0.22 μM for FKBP12). SLF can be used in the synthesis of PROTAC. | |||
T18061 | KB02-SLF | Others | Others |
KB02-SLF is a PROTAC-based nuclear FKBP12 degrader, known as a molecular glue. It facilitates the degradation of nuclear FKBP12 by covalently modifying DCAF16, an E3 ligase. Moreover, KB02-SLF enhances the longevity of protein degradation in biological systems. The compound SLF acts as a linker, binding to the ubiquitin E3 ligase ligand KB02, resulting in the formation of KB02-SLF[1]. | |||
T13914 |
SLF-amido-C2-COOH
PROTAC FKBP12-binding moiety 1 |
Others | Others |
SLF-amido-C2-COOH is a synthetic ligand for FKBP (SLF), and can be used in the synthesis of PROTACs. | |||
T73817 | SLF TFA | ||
SLF TFA 是 FK506 结合蛋白 (FKBP) 的合成配体,对FKBP51的亲和力为 3.1 μM,对FKBP12的IC50为 2.6 μM,可用于合成PROTAC 分子。 | |||
T61112 |
SLF1081851
|
LPL Receptor | GPCR/G Protein |
SLF1081851 是一种 Spns2 抑制剂,抑制 S1P 释放 (IC50=1.93 μM)。SLF1081851 在发育和免疫系统中起关键作用。 | |||
T62851 | SLF1081851 TFA | ||
SLF1081851 (TFA) 是一种 Spns2 抑制剂,抑制 S1P 释放的 IC50 值为 1.93 μM。SLF1081851 (TFA) 在发育和免疫系统中发挥着关键作用。 | |||
T74026 |
AUTAC2
|
||
AUTAC2 是一种 FKBP12靶向自噬介导降解体 (AUTAC)。AUTAC2 包含一个 FBnG 和 SLF 部分,其中 SLF 与 FKBP12 非共价结合。 | |||
T39923 |
KB02-COOH
KB02-COOH |
||
KB02-COOH is a synthetic fragment derived from ubiquitin E3 ligase ligand KB02, which possesses potential utility in the synthesis of PROTAC compounds. Notably, KB02-COOH can be employed in the generation of PROTAC constructs like KB02-JQ1 and KB02-SLF. | |||
T18597 |
dFKBP-1
|
Others | Others |
dFKBP-1 is a potent and PROTAC-based FKBP12 degrader. dFKBP-1 incorporates the ligand SLF of FKBP12, the Thalidomide based cereblon ligand and a linker[1]. | |||
T80928 |
TSPO ligand-3
|
AUTACs | PROTAC |
TSPO ligand-3为AUTAC2的配体,其中AUTAC2包含p-氟苄基鸟嘌呤(FBnG)及FKBP合成配体(SLF)两部分,能在HeLa细胞中显著沉默FKBP12蛋白。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02105 |
SCF Protein, Mouse, Recombinant (His)
Gb,Kitlg,SF,Clo,Mgf,SLF,Sl,KIT ligand,SCF,Con |
Mouse | Baculovirus Insect Cells |
SCF Protein, Mouse, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 19.7 kDa and the accession number is P20826-1. | |||
TMPY-05135 |
SCF Protein, Mouse, Recombinant (His), Biotinylated
Con,SLF,SF,Mgf,Gb,Clo,KIT ligand,Sl,Kitlg,SCF |
Mouse | Baculovirus Insect Cells |
SCF Protein, Mouse, Recombinant (His), Biotinylated is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 19.7 kDa and the accession number is P20826-1. | |||
TMPJ-00895 |
SCF Protein, Rat, Recombinant (HEK293, His)
steel factor,Mast cell growth factor,SLF,MGFSHEP7,S... |
Rat | HEK293 Cells |
SCF/C-kit ligand is the ligand of the tyrosine-kinase receptor encoded by the KIT locus. Plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. KITLG/SCF binding can activate several signaling pathways. Promotes phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and subsequent activation of the kinase AKT1. In phase I/II... | |||
TMPH-02063 |
SLFN12 Protein, Human, Recombinant (His)
|
Human | E. coli |
SLFN12 Protein, Human, Recombinant (His) is expressed in in vitro E. coli expression system. | |||
TMPH-02062 |
SLFN11 Protein, Human, Recombinant (His)
|
Human | E. coli |
SLFN11 Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-10xHis tag. The predicted molecular weight is 69.6 kDa and the accession number is Q7Z7L1. | |||
TMPK-01441 |
HLA-A*02:01&B2M&PRAME (ALYVDSLFFL) Monomer Protein, Human, MHC (His & Avi)
OIP-4,PRAME,MAPE,OIP4 |
Human | HEK293 Cells |
PRAME (PReferentially expressed Antigen in MElanoma) is a melanoma-associated antigen expressed in cutaneous and ocular melanomas and some other malignant neoplasms, while its expression in normal tissue and benign tumors is limited. |